Innovative Health Launches First Reprocessing Performance Benchmark for Electrophysiology Programs
New analysis finds the average program grew 28% in one year, while leading programs operate across nearly four times as many product families
The inaugural report finds that the average program increased reprocessed-device utilization by 28% in the latest full year. That growth came from two sources: an 18% increase in the number of distinct products used and deeper utilization of products already adopted. The finding shows that strong programs expanded both the breadth of their portfolios and the use of reprocessed devices within each product family.
The analysis also reveals a wide gap between an average program and a leading one. The average participating program used 213 reprocessed devices across seven product families. A 90th-percentile program used 2,049 devices across 27 families, nearly 10 times the device volume and almost four times the portfolio breadth.
"Hospitals often know whether their reprocessing volume is rising, but they have had no clear way to judge whether the program is keeping pace with what is possible," said
Among the report's key findings:
- Growth should be expected. The average program expanded reprocessed-device utilization 28% in one year.
- Leading programs operate at a different scale. The 90th-percentile programs used 2,049 devices across 27 product families, compared with 213 devices across seven families for the average program.
- Utilization remains concentrated. Ten product families account for 65% of all reprocessed products used, indicating that additional growth will require expansion beyond the most established parts of the portfolio.
- Several categories remain under-adopted. Mapping catheters were used by 49% of participating facilities, transseptal needles by 33%, and intravascular ultrasound devices by 31%. By comparison, diagnostic catheter adoption reached 95%.
- New technologies diffuse at radically different speeds. Leading pulsed field ablation device use grew 1,230% in 12 months compared to 135% growth for slower-diffusing radiofrequency devices. At the same time, 85% of catalogue items in the lifecycle analysis had seven or more years of meaningful volume.
Together, the findings describe an EP market moving on two timelines. New technologies can alter utilization within months, while proven products can remain clinically relevant for a decade or longer.
"A reprocessing strategy cannot be built only around last year's purchasing patterns or the newest device entering the lab," Ferreira said. "Hospitals need the operating discipline to broaden a program while continuously reassessing the portfolio. The data in this report makes both opportunities visible."
The Reprocessing Performance Benchmark includes nine implications that hospitals can test against their own program data. The full report can be downloaded here.
About Innovative Health
Innovative Health is an advanced medical device reprocessing company that offers smarter utilization of medical devices in hospitals' cardiology and electrophysiology programs.
View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-health-launches-first-reprocessing-performance-benchmark-for-electrophysiology-programs-302892980.html
SOURCE Innovative Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US-Based Thermoforming and Pressure Forming Manufacturer, Kal Plastics, to Exhibit at Southern California Design-2-Part Show
- Ditch the Dull: Refresh the Fall Wardrobe with COOFANDY for Elevated Men’s Autumn Style
- Civil Rights and Trial Attorney John Gomez Announces Wrongful Death Lawsuit After Developmentally Disabled Man Killed at Fallbrook Care Facility
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share